Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Biochemical Society Transactions|July 27, 2011
Models of dementia: an introductory overviewLindsay Graham, Calum SutherlandInternational Journal of Alzheimer'S Disease|June 2, 2011
What Are the bona fide GSK3 Substrates?Calum SutherlandThe British Journal of Psychiatry : the Journal of Mental Science|July 3, 2015
Invited commentary on … Lithium treatment and risk for dementia in adults with bipolar disorderCalum Sutherland, Ashleigh C DuthieMethods in Molecular Biology (Clifton, N.J.)|December 23, 2008
Measuring GSK3 expression and activity in cellsAdam R Cole, Calum SutherlandBMJ Open|May 12, 2023
Point-of-care testing of HbA1c levels in community settings for people with established diabetes or people at risk of developing type 2 diabetes: a systematic review and meta-analysis protocolAnna Gourlay, Calum Sutherland, Andrew RadleyFEBS Letters|August 14, 2003
Different mechanisms are used by insulin to repress three genes that contain a homologous thymine-rich insulin response elementSatish Patel, Christopher Lipina, Calum SutherlandBiochemical Pharmacology|May 29, 2012
Insulin resistance in the brain: an old-age or new-age problem?Ritchie Williamson, Alison McNeilly, Calum SutherlandPrimary Care Diabetes|November 4, 2023
Point-of-Care testing of HbA1c levels in community settings for people with established diabetes or people at risk of developing diabetes: A systematic review and meta-analysisAnna Gourlay, Calum Sutherland, Andrew RadleyCell Communication and Signaling : CCS|June 14, 2023
Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibitionJosh T Coats, Sudhir Tauro, Calum SutherlandBiochemical Pharmacology|November 6, 2017
A partnership with the proteasome; the destructive nature of GSK3Holly Robertson, John D Hayes, Calum SutherlandPageof 8